While these compounds treat the symptoms of AD rather than the underlying disease, a recent meta-analysis showed that Memantine, which blocks NMDA receptors, has shown credible efficacy when prescribed alone or in combination with cholinesterase inhibitors such as Donepezil51,52. Here, BCHE is linked to Alzheimer disease.